KLK3 and neoplasm: Notably, kataegis-postive tumours were associated with elevated prostate-specific antigen levels at presentation in African (false discovery rate = 0.002) and higher risk for metastatic progression in European patients (Kaplan-Meier estimator, P=0.03).